Angiogenesis in symptomatic intracranial atherosclerosis: predominance of the inhibitor endostatin is related to a greater extent and risk of recurrence. (Q44322045)

From Wikidata
Jump to navigation Jump to search
scientific article published on 18 November 2004
edit
Language Label Description Also known as
English
Angiogenesis in symptomatic intracranial atherosclerosis: predominance of the inhibitor endostatin is related to a greater extent and risk of recurrence.
scientific article published on 18 November 2004

    Statements

    title
    Angiogenesis in symptomatic intracranial atherosclerosis: predominance of the inhibitor endostatin is related to a greater extent and risk of recurrence (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    15550686
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15550686%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    5 January 2020
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q44322045&oldid=2109430817"